Georgetown — Washington D.C., District of Columbia

Georgetown is a clinical research site located in Washington D.C., District of Columbia, United States 20007.

Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

Georgetown has participated in 6 clinical trials with 1 currently active.

Therapeutic areas: Metastatic Cancer, Solid Tumors, Colorectal Cancer (CRC).

Sponsors: Incyte Corporation, Matrix Biomed, Inc., Catherine Bollard.

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Georgetown?

Georgetown has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Georgetown conducted?

Georgetown has 6 clinical trials on record, with 1 currently active. Their work covers Metastatic Cancer, Solid Tumors, Colorectal Cancer (CRC).

Is Georgetown accredited by Crixeo Health?

Yes — Georgetown holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Georgetown?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.